• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析中的氧化应激

Oxidative stress in hemodialysis.

作者信息

Himmelfarb Jonathan

机构信息

Department of Medicine, Division of Nephrology and Renal Transplantation, Maine Medical Center, Portland, Me., USA.

出版信息

Contrib Nephrol. 2008;161:132-137. doi: 10.1159/000130658.

DOI:10.1159/000130658
PMID:18451669
Abstract

Patients with advanced chronic kidney disease are at a greatly increased cardiovascular risk that cannot be explained entirely by traditional cardiovascular risk factors. An increase in oxidative stress is proposed as a non-traditional cardiovascular risk factor in this patient population. Many laboratories have now unequivocally demonstrated that uremia is an increased oxidative stress state. Uremic oxidative stress is characterized biologically by an increase in lipid peroxidation products and reactive aldehyde groups as well as by increased retention of oxidized thiols. The pathophysiology of increased oxidative stress in uremia is multifactorial, but the retention of oxidized solute by the loss of kidney function is probably a major contributor.

摘要

晚期慢性肾病患者的心血管风险大幅增加,而传统心血管风险因素并不能完全解释这一现象。氧化应激增加被认为是该患者群体中的一种非传统心血管风险因素。现在许多实验室已经明确证明,尿毒症是一种氧化应激增加的状态。尿毒症氧化应激的生物学特征是脂质过氧化产物和活性醛基增加,以及氧化型硫醇的潴留增加。尿毒症中氧化应激增加的病理生理学是多因素的,但肾功能丧失导致氧化溶质的潴留可能是一个主要因素。

相似文献

1
Oxidative stress in hemodialysis.血液透析中的氧化应激
Contrib Nephrol. 2008;161:132-137. doi: 10.1159/000130658.
2
Relevance of oxidative pathways in the pathophysiology of chronic kidney disease.氧化途径在慢性肾脏病病理生理学中的相关性
Cardiol Clin. 2005 Aug;23(3):319-30. doi: 10.1016/j.ccl.2005.03.005.
3
Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.尿毒症毒性、氧化应激与作为肾脏替代疗法的血液透析
Semin Dial. 2009 Nov-Dec;22(6):636-43. doi: 10.1111/j.1525-139X.2009.00659.x.
4
Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?肾病中氧化应激与炎症的关联:孰因孰果?
Semin Dial. 2004 Nov-Dec;17(6):449-54. doi: 10.1111/j.0894-0959.2004.17605.x.
5
The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.尿毒症中的“大象”:氧化应激作为尿毒症心血管疾病的统一概念。
Kidney Int. 2002 Nov;62(5):1524-38. doi: 10.1046/j.1523-1755.2002.00600.x.
6
[Chronic renal disease, inflammation and atherosclerosis: new concepts about an old problem].[慢性肾病、炎症与动脉粥样硬化:关于一个老问题的新观念]
Rev Assoc Med Bras (1992). 2007 Sep-Oct;53(5):446-50. doi: 10.1590/s0104-42302007000500022.
7
Oxidative stress and inflammation: Implications in uremia and hemodialysis.氧化应激和炎症:在尿毒症和血液透析中的意义。
Clin Biochem. 2011 Oct;44(14-15):1189-98. doi: 10.1016/j.clinbiochem.2011.06.988. Epub 2011 Jul 12.
8
Iron supplementation and oxidative stress in patients with uremia.尿毒症患者的铁补充与氧化应激
Indian J Physiol Pharmacol. 2007 Apr-Jun;51(2):179-82.
9
Effects of dialysis purity on uremic dyslipidemia.透析纯度对尿毒症血脂异常的影响。
Ther Apher Dial. 2010 Feb;14(1):5-11. doi: 10.1111/j.1744-9987.2009.00713.x.
10
[Inflammatoin, oxidative stress and carbonyl stress in uremic patients].[尿毒症患者的炎症、氧化应激和羰基应激]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Jan;37(1):123-5.

引用本文的文献

1
Fistula first, catheter last: can the mouth be second?先造瘘,后置管:口腔能排第二吗?
Front Nephrol. 2024 May 23;4:1385544. doi: 10.3389/fneph.2024.1385544. eCollection 2024.
2
The effect of aerobic exercise on oxidative stress in patients with chronic kidney disease: a systematic review and meta-analysis with trial sequential analysis.有氧运动对慢性肾脏病患者氧化应激的影响:系统评价和试验序贯分析。
Ren Fail. 2023;45(2):2252093. doi: 10.1080/0886022X.2023.2252093. Epub 2023 Sep 27.
3
The role of neuroimmune and inflammation in pediatric uremia-induced neuropathy.
神经免疫和炎症在小儿尿毒症性神经病中的作用。
Front Immunol. 2022 Sep 15;13:1013562. doi: 10.3389/fimmu.2022.1013562. eCollection 2022.
4
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy.用于慢性血液透析治疗的表面改性膜的生物相容性
Biomedicines. 2022 Apr 3;10(4):844. doi: 10.3390/biomedicines10040844.
5
The effects of vitamin E supplementation on malondialdehyde as a biomarker of oxidative stress in haemodialysis patients: a systematic review and meta-analysis.维生素 E 补充剂对血液透析患者氧化应激生物标志物丙二醛的影响:系统评价和荟萃分析。
BMC Nephrol. 2021 Apr 9;22(1):126. doi: 10.1186/s12882-021-02328-8.
6
Two Toxic Lipid Aldehydes, 4-hydroxy-2-hexenal (4-HHE) and 4-hydroxy-2-nonenal (4-HNE), Accumulate in Patients with Chronic Kidney Disease.两种毒性脂质醛,4-羟基-2-己烯醛(4-HHE)和 4-羟基-2-壬烯醛(4-HNE),在慢性肾脏病患者体内蓄积。
Toxins (Basel). 2020 Sep 3;12(9):567. doi: 10.3390/toxins12090567.
7
Protein Carbonyl Content Is a Predictive Biomarker of Eccentric Left Ventricular Hypertrophy in Hemodialysis Patients.蛋白质羰基含量是血液透析患者离心性左心室肥厚的预测生物标志物。
Diagnostics (Basel). 2019 Nov 25;9(4):202. doi: 10.3390/diagnostics9040202.
8
The biocompatibility and bioactivity of hemodialysis membranes: their impact in end-stage renal disease.血液透析膜的生物相容性和生物活性:它们对终末期肾病的影响。
J Artif Organs. 2019 Mar;22(1):14-28. doi: 10.1007/s10047-018-1059-9. Epub 2018 Jul 14.
9
Novel PAradigm to improve Inflammatory burden in end stage Renal disease (rePAIR): study protocol for a randomized controlled trial.改善终末期肾病炎症负担的新型范式(rePAIR):一项随机对照试验的研究方案
Trials. 2018 Jul 11;19(1):370. doi: 10.1186/s13063-018-2760-y.
10
LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.LCZ696(沙库巴曲/缬沙坦)在慢性肾脏病中除了具有血管紧张素受体阻断作用外,还能减轻氧化应激、炎症和纤维化,并改善肾功能。
Am J Transl Res. 2017 Dec 15;9(12):5473-5484. eCollection 2017.